초록

The present invention relates to microcapsules comprising a wall and an aqueous core comprising various active agents, and prepared by the interfacial reaction in aqueous medium of Lewis acid and base wall-forming reactants.

대표청구항 ▼

1. A process for preparing a microcapsule comprising an aqueous core surrounded by a capsular wall, said capsular wall comprising a Lewis salt of an amine and an anionic polymer, said process comprising the steps of: a) selecting a water soluble a anionic polymer, or water soluble salt thereof, a

1. A process for preparing a microcapsule comprising an aqueous core surrounded by a capsular wall, said capsular wall comprising a Lewis salt of an amine and an anionic polymer, said process comprising the steps of: a) selecting a water soluble a anionic polymer, or water soluble salt thereof, and a water soluble amine, or water soluble salt thereof, said anionic polymer and said amine being selected from pairs of anionic polymer and amine having the property that when droplets of an aqueous liquid solution of the anionic polymer are introduced into an aqueous liquid solution of said amine, stable microcapsules of the amine salt of the anionic polymer are formed; b) dissolving said anionic polymer, or salt thereof, in water to form an anionic polymer liquid solution; c) dissolving said amine, or salt thereof, in water to form an amine liquid solution; d) dissolving or suspending an active ingredient in said anionic polymer liquid solution of step b) so that a liquid composition is formed; e) forming a droplet of said liquid composition resulting from step d); f) adding said droplet of said liquid composition to said amine liquid solution; and g) allowing said droplet of said liquid composition and said amine liquid solution to react at their mutual interface boundary to form said microcapsule. 2. The process according to claim 1 wherein said anionic polymer is selected from the group consisting of alginic acids, alginic acids linked to a fluorophore, arabic acid, cellulose sulfate, carbokymethylcellulose, carrageenans, chondroitin sulfate, heparin, polyacrylic acid, polyoxyethylene cross-linked polyacrylic acid and polyvinylcarboxylic acid. 3. The process according to claim 1 wherein the amine is selected from the group consisting of arginine, decylamine, dodecylamine, ethylenediamine, piperazine, methylene blue, octadecylamine, triethylamine, triethylenetetramine and spermine. 4. The process according to claim 1 wherein said microcapsule has a particle size between 0.1 and 2,000 microns. 5. The process according to claim 1 wherein, in step d), said active ingredient is suspended in said anionic polymer liquid solution. 6. The process according to claim 5 wherein the active ingredient is a drug. 7. The process according to claim 5 wherein said active ingredient is an immunogenic substance. 8. The process according to claim 7 wherein the immunogenic substance is a viral particle. 9. The process according to claim 7 wherein said immunogenic substance is a rotavirus. 10. The process according to claim 2 wherein said anionic polymer liquid solution has a viscosity of at least 2.5 centipose.